Comparing composite scores based on maximal voluntary isometric contraction and oil semiquantitative manual motor testing in measuring limb strength in patients with ALS

被引:4
作者
Armon, C
Ponraj, E
机构
[1] Department of Neurology, Loma Linda Univ. School of Medicine, Loma Linda, CA
[2] Loma Linda University Medical Center, Department of Neurology, Loma Linda, CA 92354
关键词
D O I
10.1212/WNL.47.6.1586
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Maximal voluntary isometric contraction (MVIC) is a standardized tool for measuring disease progression in patients with ALS. After normalization, summation, and averaging, it generates composite scores (CS) (''megascores''). In a cross-sectional study, these scores were highly correlated with ''average strength'' composite scores based on semi- quantitative manual motor testing (SQMMT): r=0.697 (p <0.0001). Each 10% difference in the raw SQMMT-CS corresponds to a 0.56 difference in the MVIC-CS (95% confidence limits [CL], 0.38, 0.14). Controlling for height (a highly significant-covariate, p <0.0001), each 10% difference in SQMMT-CS corresponds to a 0.39 difference in MVIC-CS (95% CL, 0.24, 0.54).
引用
收藏
页码:1586 / 1587
页数:2
相关论文
共 10 条
[1]
QUANTITATIVE MOTOR-ASSESSMENT IN AMYOTROPHIC-LATERAL-SCLEROSIS [J].
ANDRES, PL ;
HEDLUND, W ;
FINISON, L ;
CONLON, T ;
FELMUS, M ;
MUNSAT, TL .
NEUROLOGY, 1986, 36 (07) :937-941
[2]
USE OF COMPOSITE SCORES (MEGASCORES) TO MEASURE DEFICIT IN AMYOTROPHIC LATERAL SCLEROSIS [J].
ANDRES, PL ;
FINISON, LJ ;
CONLON, T ;
THIBODEAU, LM ;
MUNSAT, TL .
NEUROLOGY, 1988, 38 (03) :405-408
[3]
A RATING-SCALE FOR AMYOTROPHIC-LATERAL-SCLEROSIS - DESCRIPTION AND PRELIMINARY EXPERIENCE [J].
APPEL, V ;
STEWART, SS ;
SMITH, G ;
APPEL, SH .
ANNALS OF NEUROLOGY, 1987, 22 (03) :328-333
[4]
ARMON C, 1994, HDB NEUROEPIDEMIOLOG, P407
[5]
HUMAN DIABETIC ENDONEURIAL SORBITOL, FRUCTOSE, AND MYOINOSITOL RELATED TO SURAL NERVE MORPHOMETRY [J].
DYCK, PJ ;
SHERMAN, WR ;
HALLCHER, LM ;
SERVICE, FJ ;
OBRIEN, PC ;
GRINA, LA ;
PALUMBO, PJ ;
SWANSON, CJ .
ANNALS OF NEUROLOGY, 1980, 8 (06) :590-596
[6]
*MAY CLIN, 1981, CLIN EX NEUR, P131
[7]
A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis [J].
Miller, RG ;
Petajan, JH ;
Bryan, WW ;
Armon, C ;
Barohn, RJ ;
Goodpasture, JC ;
Hoagland, RJ ;
Parry, GJ ;
Ross, MA ;
Stromatt, SC ;
Belsh, JM ;
Buchman, AS ;
Donofrio, PD ;
Eisen, AA ;
Gan, RA ;
Gutmann, L ;
Horowitz, SH ;
Jackson, WS ;
Johnston, WS ;
Kelly, JJ ;
Malta, E ;
Mandler, RN ;
Massey, JM ;
McGuire, D ;
Newman, DS ;
Pascuzzi, RM ;
Phillips, LH ;
Ravits, JM ;
Rivner, MH ;
Rubin, M ;
Russo, LS ;
Sergay, SM ;
Sumner, AJ ;
Swenson, MR ;
Teitel, L .
ANNALS OF NEUROLOGY, 1996, 39 (02) :256-260
[8]
ADMINISTRATION OF GUANIDINE IN AMYOTROPHIC LATERAL SCLEROSIS [J].
NORRIS, FH ;
CALANCHINI, PR ;
FALLAT, RJ ;
PANCHARI, S ;
JEWETT, B .
NEUROLOGY, 1974, 24 (08) :721-728
[9]
ROSS MA, 1995, NEUROLOGY, V45, pA280
[10]
RECOMBINANT GROWTH-HORMONE TREATMENT OF AMYOTROPHIC-LATERAL-SCLEROSIS [J].
SMITH, RA ;
MELMED, S ;
SHERMAN, B ;
FRANE, J ;
MUNSAT, TL ;
FESTOFF, BW .
MUSCLE & NERVE, 1993, 16 (06) :624-633